Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single ascending dose study of JTK-656 with food-effect assessment in healthy men
NL-OMON32420Phase 1Active, not recruiting
- Sponsor
- Japan Tobacco
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of JTK-656 in Human immunodeficiency virus infection type 1 (4 arms), sponsored by Japan Tobacco. Primary endpoint: Safety and tolerability. Started Aug 2008; status: active, not recruiting.
02
Drugs
JTK-656
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON32420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32420.